Leena Gandhi

机构：Celldex Therapeutics (United States) · ORCID：0000-0002-2398-9179

发表论文 342 篇 · 总被引 37088 次 · h-index 60

代表论文

• A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer (2023 · BMC Cancer · 被引 67)
• Identifying Oncology Clinical Trial Candidates Using Artificial Intelligence Predictions of Treatment Change: A Pilot Implementation Study (2024 · JCO Precision Oncology · 被引 9)
• Enfortumab vedotin in patients with advanced non-small cell lung cancer after disease progression on platinum- and PD-1/PD-L1 inhibitor-containing regimens: Phase 2 international multicenter EV-202 study (2025 · European Journal of Cancer · 被引 7)
• Enfortumab vedotin (EV) in non-squamous and squamous non–small cell lung cancer (NSCLC) cohorts of EV-202. (2024 · Journal of Clinical Oncology · 被引 4)
• Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies (2025 · Clinical Lung Cancer · 被引 1)
• Mapping MAGE-A4 expression in solid cancers for targeted therapies (2025 · Frontiers in Oncology · 被引 1)